NEW DELHIâ€”India's government placed new price controls on more than 100 diabetes and heart-disease drugs, broadening the scope of medicines subject to such limits in a move likely to pinch profits of international pharmaceutical companies in the world's second-most-populous country.. The National Pharmaceutical Pricing Authority posted a notice on its website Friday that said large gaps in prices between brand-name and generic versions of the same drug were "indicative of a severe market failure." It cited a regulation...
  